PRP vs PRF in Management of Striae Distensae
NCT: NCT07561671 · COMPLETED
Brief Summary
A split-side comparative clinical study evaluating the efficacy and safety of injectable platelet-rich fibrin (PRF) versus platelet-rich plasma (PRP), alone or combined with microneedling, in the treatment of striae distensae. Thirty patients received PRF or PRP on one side and combination therapy with microneedling on the contralateral side over five sessions. Outcomes included striae width, length, severity score, and patient satisfaction
Frequently Asked Questions
What is PRP vs PRF in Management of Striae Distensae?
PRP vs PRF in Management of Striae Distensae is a clinical trial registered under NCT07561671. Current status: COMPLETED.
What is the status of NCT07561671?
The current status of NCT07561671 (PRP vs PRF in Management of Striae Distensae) is: COMPLETED.
When did PRP vs PRF in Management of Striae Distensae start?
PRP vs PRF in Management of Striae Distensae started on 2024-02-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.